Response Biomed Corp RPBIF

RE: RE: RE: RE: Financials

[noleafclover]

Anybody who has actually toured the facility itself (I did in June after the AGM) will see that the facility itself is huge with many different components/rooms.   The one thing I noticed is the large volume of empty floorspace; you could see that in the same way as a cup being half full or half empty, drawing your own conclusions.  The reason they chose that facility was it has the room for growth that they anticipate.  Where are they in that growth cycle?  I imagine 3rd q will show us some improvement over 2nd q, but only marginal (ie. $500,000-$1,000,000 increase in sales).  4th q will show much more impressive gains ($2,000,000 increase over Q3 IMHO).  Still, they won't be cashflow positive, but they'll be a lot closer. 
We won't be out of the woods and away from this stinking shareprice until the product gains traction, and I believe, as Hippygirl has said, that 3M and Roche are more than capable of selling this product.